β-catenin signaling induces the osteoblastogenic differentiation of human pre-osteoblastic and bone marrow stromal cells mainly through the upregulation of osterix expression

Liu,Bo; Wu,Song; Han,Lihua; Zhang,Chaoyue

doi:10.3892/ijmm.2015.2382

β-catenin signaling induces the osteoblastogenic differentiation of human pre-osteoblastic and bone marrow stromal cells mainly through the upregulation of osterix expression

Authors:
- Bo Liu
- Song Wu
- Lihua Han
- Chaoyue Zhang
View Affiliations

Affiliations: Department of Orthopaedics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, P.R. China
Published online on: October 20, 2015 https://doi.org/10.3892/ijmm.2015.2382
Pages: 1572-1582
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Both β-catenin (β-cat) and osterix (OSX) are known to be essential for embryonic and postnatal osteoblast differentiation and bone growth. In the present study, we explored the crosstalk between β-cat signaling and OSX, and assessed its effect on the osteoblastogenic differentiation of human pre-osteoblastic cells (MG-63) and bone marrow stromal cells (HS-27A). In the HS-27A and MG-63 cells, the selective β-cat signaling inhibitor, CCT031374, and the stable overexpression of a constitutively active β-cat mutant respectively decreased and increased the cytoplasmic/soluble β-cat levels, and respectively decreased and increased TOPflash reporter activity, the mRNA levels of β-cat signaling target genes c-Myc and c-Jun, as well as the mRNA and protein expression levels of OSX. Mutational analyses and electrophoretic mobility shift assays revealed that the increased binding activity of c-Jun at a putative c-Jun binding site (-858/-852 relative to the translation start codon, which was designated as +1) in the human OSX gene promoter was required for teh β-cat signaling-induced expression of OSX in the HS-27A and MG-63 cells. During osteoblastogenic culture, stimulating β-cat signaling activity by the stable overexpression of the active β-cat mutant markedly increased alkaline phosphatase (ALP) activity and calcium deposition in the HS-27A and MG-63 cells, which was abolished by knocking down OSX using shRNA. On the other hand, the inhibition of β-cat signaling activity with CCT031374 decreased the ALP activity and calcium deposition, which was completely reversed by the overexpression of OSX. On the whole, the findings of our study suggest that β-cat signaling upregulates the expression of OSX in human pre-osteoblastic and bone marrow stromal cells by trans-activating the OSX gene promoter mainly through increased c-Jun binding at a putative c-Jun binding site; OSX largely mediates β-cat signaling-induced osteoblastogenic differentiation. The present study provides new insight into the molecular mechanisms underlying osteoblast differentiation.

View Figures

View References

1	Zhou X, Zhang Z, Feng JQ, Dusevich VM, Sinha K, Zhang H, Darnay BG and de Crombrugghe B: Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc Natl Acad Sci USA. 107:12919–12924. 2010. View Article : Google Scholar : PubMed/NCBI
2	Rodda SJ and McMahon AP: Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 133:3231–3244. 2006. View Article : Google Scholar : PubMed/NCBI
3	Zhang C, Cho K, Huang Y, Lyons JP, Zhou X, Sinha K, McCrea PD and de Crombrugghe B: Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci USA. 105:6936–6941. 2008. View Article : Google Scholar : PubMed/NCBI
4	Timpson NJ, Tobias JH, Richards JB, Soranzo N, Duncan EL, Sims AM, Whittaker P, Kumanduri V, Zhai G, Glaser B, et al: Common variants in the region around Osterix are associated with bone mineral density and growth in childhood. Hum Mol Genet. 18:1510–1517. 2009. View Article : Google Scholar : PubMed/NCBI
5	Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Snorradóttir S, Center JR, et al: New sequence variants associated with bone mineral density. Nat Genet. 41:15–17. 2009. View Article : Google Scholar
6	Chesire DR and Isaacs WB: Beta-catenin signaling in prostate cancer: an early perspective. Endocr Relat Cancer. 10:537–560. 2003. View Article : Google Scholar
7	Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL and Williams BO: Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem. 280:21162–21168. 2005. View Article : Google Scholar : PubMed/NCBI
8	Liu Y and Jiang YG: Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation via β-catenin signaling. PLoS One. 9:e1113432014. View Article : Google Scholar
9	Cawthorn WP, Heyd F, Hegyi K and Sethi JK: Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ. 14:1361–1373. 2007. View Article : Google Scholar : PubMed/NCBI
10	Sun P, Xiong H, Kim TH, Ren B and Zhang Z: Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Mol Pharmacol. 69:520–531. 2006. View Article : Google Scholar
11	Messeguer X, Escudero R, Farré D, Núñez O, Martínez J and Albà MM: PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 18:333–334. 2002. View Article : Google Scholar : PubMed/NCBI
12	Farré D, Roset R, Huerta M, Adsuara JE, Roselló L, Albà MM and Messeguer X: Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31:3651–3653. 2003. View Article : Google Scholar : PubMed/NCBI
13	Wang H, Zhou M, Brand J and Huang L: Inflammation activates the interferon signaling pathways in taste bud cells. J Neurosci. 27:10703–10713. 2007. View Article : Google Scholar : PubMed/NCBI
14	Johnson DR, Levanat S and Bale AE: Direct molecular analysis of archival tumor tissue for loss of heterozygosity. Biotechniques. 19:190–192. 1995.PubMed/NCBI
15	Baylan N, Bhat S, Ditto M, Lawrence JG, Lecka-Czernik B and Yildirim-Ayan E: Polycaprolactone nanofiber interspersed collagen type-I scaffold for bone regeneration: a unique injectable osteogenic scaffold. Biomed Mater. 8(045011)2013. View Article : Google Scholar : PubMed/NCBI
16	Stratford EW, Daffinrud J, Munthe E, Castro R, Waaler J, Krauss S and Myklebost O: The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines. Cancer Med. 3:36–46. 2014. View Article : Google Scholar : PubMed/NCBI
17	Ferreira E, Porter RM, Wehling N, O'Sullivan RP, Liu F, Boskey A, Estok DM, Harris MB, Vrahas MS, Evans CH and Wells JW: Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow. J Biol Chem. 288:29494–29505. 2013. View Article : Google Scholar : PubMed/NCBI
18	Ewan K, Pajak B, Stubbs M, Todd H, Barbeau O, Quevedo C, Botfield H, Young R, Ruddle R, Samuel L, et al: A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription. Cancer Res. 70:5963–5973. 2010. View Article : Google Scholar : PubMed/NCBI
19	Sikavitsas VI, Bancroft GN, Holtorf HL, Jansen JA and Mikos AG: Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA. 100:14683–14688. 2003. View Article : Google Scholar : PubMed/NCBI
20	Dias NJ and Selcer KW: Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells. Steroids. 88:77–82. 2014. View Article : Google Scholar : PubMed/NCBI
21	Kim HK, Kim MG and Leem KH: Collagen hydrolysates increased osteogenic gene expressions via a MAPK signaling pathway in MG-63 human osteoblasts. Food Funct. 5:573–578. 2014. View Article : Google Scholar : PubMed/NCBI
22	Vallet S, Pozzi S, Patel K, Vaghela N, Fulciniti MT, Veiby P, Hideshima T, Santo L, Cirstea D, Scadden DT, et al: A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function. Leukemia. 25:1174–1181. 2011. View Article : Google Scholar : PubMed/NCBI
23	Halazonetis TD, Georgopoulos K, Greenberg ME and Leder P: c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell. 55:917–924. 1988. View Article : Google Scholar : PubMed/NCBI
24	Stein GS and Lian JB: Molecular mechanisms mediating developmental and hormone-regulated expression of genes in osteoblasts: an integrated relationship of cell growth and differentiation. Cellular and molecular biology of bone. Noda M: Academic Press; Tokyo: pp. 47–95. 1993
25	Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR and de Crombrugghe B: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:17–29. 2002. View Article : Google Scholar : PubMed/NCBI